Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $866.82 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $159.96 | 11 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $142.46 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $89.97 | 6 | $0 (2023) |
| PFIZER INC. | $89.97 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.03 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $57.59 | 4 | $0 (2021) |
| Novo Nordisk Inc | $56.04 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $49.81 | 4 | $0 (2019) |
| Boston Scientific Corporation | $48.38 | 3 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $33.22 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $37.60 | 2 | Janssen Pharmaceuticals, Inc ($22.37) |
| 2022 | $113.11 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($51.48) |
| 2021 | $85.90 | 6 | AbbVie Inc. ($22.05) |
| 2020 | $46.37 | 3 | Janssen Pharmaceuticals, Inc ($29.00) |
| 2019 | $183.93 | 12 | Novo Nordisk Inc ($56.04) |
| 2018 | $214.38 | 11 | PFIZER INC. ($78.44) |
| 2017 | $185.53 | 12 | E.R. Squibb & Sons, L.L.C. ($93.29) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2019 | Novo Nordisk Inc | Levemir (Drug), Tresiba | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Diabetes | ||||||
| 08/23/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/06/2019 | Novo Nordisk Inc | Levemir (Drug), Tresiba | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 02/28/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 02/08/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/03/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2018 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $67.84 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/07/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/30/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.91 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/17/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Respiratory | ||||||
| 03/29/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/13/2018 | Merck Sharp & Dohme Corporation | CUBICIN RF (Drug), ZERBAXA, SIVEXTRO | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/28/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: Cardiovascular | ||||||
| 02/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Cardiovascular | ||||||
| 01/24/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.68 | General |
| Category: Cardiovascular | ||||||
| 11/27/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.99 | General |
| Category: Cardiovascular | ||||||
| 10/24/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: Cardiovascular | ||||||
| 10/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.03 | General |
| Category: Cardiovascular | ||||||
| 10/06/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: Cardiovascular | ||||||
| 09/07/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/09/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 344 | 460 | $293,671 | $38,105 |
| 2022 | 8 | 382 | 569 | $90,951 | $38,147 |
| 2021 | 9 | 457 | 617 | $102,759 | $43,905 |
| 2020 | 9 | 449 | 615 | $100,700 | $44,655 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 123 | $84,010 | $11,456 | 13.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 144 | $57,040 | $8,950 | 15.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 58 | 58 | $78,476 | $7,522 | 9.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 77 | 78 | $34,359 | $4,816 | 14.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $20,848 | $2,762 | 13.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 29 | 29 | $18,938 | $2,600 | 13.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 148 | 319 | $40,194 | $17,031 | 42.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 49 | 65 | $11,700 | $5,044 | 43.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 37 | $8,732 | $3,823 | 43.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 44 | 44 | $11,000 | $3,602 | 32.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 23 | $7,958 | $3,349 | 42.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 50 | 50 | $6,150 | $2,699 | 43.9% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $3,618 | $1,872 | 51.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 13 | 13 | $1,599 | $726.92 | 45.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 160 | 296 | $37,296 | $16,550 | 44.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 58 | 79 | $14,220 | $6,238 | 43.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 35 | $12,110 | $5,401 | 44.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 39 | 39 | $9,204 | $4,049 | 44.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 48 | 49 | $12,250 | $4,000 | 32.7% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 35 | 35 | $7,035 | $3,179 | 45.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 53 | 53 | $6,519 | $2,955 | 45.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 18 | 18 | $2,214 | $909.12 | 41.1% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 11 | 13 | $1,911 | $625.46 | 32.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 153 | 295 | $37,170 | $17,122 | 46.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 42 | 62 | $11,160 | $5,127 | 45.9% |
About Dr. Penny Rathburn, DO
Dr. Penny Rathburn, DO is a Internal Medicine healthcare provider based in Saint Joseph, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063555944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Penny Rathburn, DO has received a total of $866.82 in payments from pharmaceutical and medical device companies, with $37.60 received in 2023. These payments were reported across 54 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($866.82).
As a Medicare-enrolled provider, Rathburn has provided services to 1,632 Medicare beneficiaries, totaling 2,261 services with total Medicare billing of $164,813. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Saint Joseph, MI
- Active Since 02/14/2007
- Last Updated 10/14/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1063555944
Products in Payments
- ELIQUIS (Drug) $157.29
- ENTRESTO (Drug) $127.23
- XARELTO (Drug) $89.97
- CHANTIX (Drug) $78.44
- JARDIANCE (Drug) $77.03
- Levemir (Drug) $38.82
- ZERBAXA (Drug) $38.03
- LifeVest (Device) $33.22
- WATCHMAN Access System (Device) $31.01
- DALVANCE (Drug) $22.05
- WATCHMAN (Device) $17.37
- SYMBICORT (Drug) $17.32
- Tresiba (Drug) $17.22
- LEQVIO (Drug) $15.23
- BRILINTA (Drug) $14.98
- Kimyrsa (Drug) $14.96
- CAMZYOS (Drug) $14.20
- LOKELMA (Drug) $14.18
- MINOCIN IV (Drug) $13.40
- Veklury (Drug) $11.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Joseph
Thomas Birris, Md, MD
Internal Medicine — Payments: $49,270
Ahmad Al-Mubaslat, Md, MD
Internal Medicine — Payments: $38,625
Bhaskar Bhardwaj, M.d, M.D
Internal Medicine — Payments: $34,454
Dr. Jeffrey Grondin, M.d, M.D
Internal Medicine — Payments: $21,154
German Kamalov, Md, MD
Internal Medicine — Payments: $20,960
Mr. Narayana Gandham, M.d, M.D
Internal Medicine — Payments: $17,522